Skip to main content
. Author manuscript; available in PMC: 2024 Jan 5.
Published in final edited form as: Clin Cancer Res. 2023 Jul 5;29(13):2394–2400. doi: 10.1158/1078-0432.CCR-23-0036

Figure 3. Kaplan-Meier analyses of progression-free survival and overall survival.

Figure 3.

The median progression-free survival (red line) was 10.0 (95% CI, 7.1 – 14.9) months. The median overall survival (blue line) is not estimable after a median follow-up of 15.6 months.